Royal Society of Chemistry, Nanoscale, 35(12), p. 18022-18030, 2020
DOI: 10.1039/d0nr03784b
Full text: Unavailable
A new hybrid gene delivery platform (mCVT) remarkably improves the transfection efficiency of hard-to-transfect (HTT) cells, while preserving excellent biocompatibility.